292 related articles for article (PubMed ID: 33534722)
1. Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study.
Dai W; Ke PF; Li ZZ; Zhuang QZ; Huang W; Wang Y; Xiong Y; Huang XZ
J Med Internet Res; 2021 Feb; 23(2):e23390. PubMed ID: 33534722
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of blood parameters for community-acquired pneumonia.
Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
[TBL] [Abstract][Full Text] [Related]
3. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia.
Ito A; Ishida T; Tachibana H; Arita M; Yamazaki A; Washio Y
Clin Chem Lab Med; 2019 Sep; 57(10):1632-1637. PubMed ID: 31120857
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia.
Zheng N; Zhu D; Han Y
BMC Pulm Med; 2020 Jun; 20(1):166. PubMed ID: 32527243
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of plasma heparin-binding protein and the heparin-binding protein-to-albumin ratio in patients with community-acquired Pneumonia: a retrospective study.
Xiao X; Hong Y; Wang S; Ma M; Xu Z
BMC Infect Dis; 2023 Nov; 23(1):777. PubMed ID: 37946099
[TBL] [Abstract][Full Text] [Related]
6. The value of PCT, IL-6, and CRP in the early diagnosis and evaluation of COVID-19.
Zhou YZ; Teng XB; Han MF; Shi JF; Li CX; Zhang XH; Hou DY; Yang LL
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):1097-1100. PubMed ID: 33577066
[TBL] [Abstract][Full Text] [Related]
7. Serum Procalcitonin, White Blood Cell and Hypersensitive C-reactive Protein Combined with Age Established a New Prediction Model in Predicting ICU Admission in Adult Community-Acquired Pneumonia (CAP) Patients.
Li WQ; Chen Y; Liu TJ; Xie BQ; Fu AS; Li LQ; Ge YL; Min P; Lu Y; Liu Y; Sun Y; Hou LL; Jing Q; Zhang HF; Zhang JB
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390385
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
9. Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study.
Sang S; Sun R; Coquet J; Carmichael H; Seto T; Hernandez-Boussard T
J Med Internet Res; 2021 Feb; 23(2):e23026. PubMed ID: 33534724
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
[TBL] [Abstract][Full Text] [Related]
12. The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.
Guo S; Mao X; Liang M
Respir Res; 2018 Oct; 19(1):193. PubMed ID: 30285748
[TBL] [Abstract][Full Text] [Related]
13. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
14. [Construction and verification of a nomogram prediction model of severe adult community-acquired pneumonia].
Wang Z; Qu Y; Huang M; Zhu Y; Peng D; Yu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Sep; 34(9):935-940. PubMed ID: 36377447
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes.
Ge YL; Zhang HF; Zhang Q; Zhu XY; Liu CH; Wang N; Zhang JB; Chen H; Chen Y; Li WQ; Li ZZ; Fu AS; Wang HY
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115235
[TBL] [Abstract][Full Text] [Related]
17. The pneumonia severity index: Assessment and comparison to popular machine learning classifiers.
Wang D; Willis DR; Yih Y
Int J Med Inform; 2022 Jul; 163():104778. PubMed ID: 35487075
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
19. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of copeptin in distinguishing COVID-19 pneumonia from community-acquired pneumonia.
Kuluöztürk M; İn E; Telo S; Karabulut E; Geçkil AA
J Med Virol; 2021 May; 93(5):3113-3121. PubMed ID: 33570194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
